TCTR20210831002招募中不适用
Pattern of antibody response after 3rd dose of COVID-19 vaccine booster among healthy volunteers.
akornping Hospital0 个研究点目标入组 180 人开始时间: 2021年8月31日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 180
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 30 Years 至 60 Years（—）
- 性别
- All
入选标准
- •healthy volunteer
排除标准
- •1.Diabetes 2. CKD 3. immune deficiency status 4. taking immune modulator drugs 5. obesity with BMI over 35 or BW > 100 kg.6. cancer 7. pregnant 8. lactaing women 9. postpartum women 10. has been diagnosed of Covid-19 infection 11. taking prednisolone > 20 mg/day within 1 months
研究者
相似试验
招募中
不适用
Pattern of antibody response after 4th dose of COVID-19 vaccine booster among healthy volunteershealthy volunteersCOVID-19 Vaccines administration and dosage immunologyTCTR20220217001akornping hospital180
已完成
不适用
Serial antibody progression after 3rd dose of vaccination in thoracic organ transplant patients with inadequate immune response after dual protective vaccination against SARS-CoV-2 coronavirusheart transplantationcoronavirus diseaseDRKS00028865Herz- und Diabeteszentrum NRW, Klinik für Thorax-und Kardiovaskularchirurgie390
招募中
2 期
Immunogenicity and safety of the third dose COVID-19 vaccine in Thai population.After the third dose of the COVID-19 vaccine, the immune response in healthy volunteers who received 2 doses of COVID19 vaccine (CoronaVac or ChAdOx1) at least three months.COVID-19 vaccine, Third dose, ChAdOx1, coronavac, Sinovac, BNT162b2, SinopharmTCTR20210731004Chulabhorn Royal Academy5,520
招募中
2 期
Immunogenicity and safety of the third dose COVID-19 vaccine via intradermal compare with intramuscular administration (Randomized controlled trial)The immune response after the third dose of the COVID-19 vaccine via intradermal administration in healthy volunteers.COVID-19 vaccine, Third dose, intradermal, ChAdOx1, coronavac, Sinovac, BNT162b2, mRNA1263, SinopharmTCTR20210731003Chulabhorn Royal Academy960
进行中（未招募）
不适用
Immunogenicity of the 3rd COVID-19 vaccine dose in Thai healthcare workers at Bamrasnaradura Infectious Diseases InstituteHealthcare workers who received two doses of SinovacCOVID-19 VaccineSARS-CoV-2AntibodyHealthcare WorkersAstraZenecaPfizerTCTR20211005001ational Research Council of Thailand (NRCT)170